BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20190819)

  • 1. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
    Breig O; Théoleyre O; Douablin A; Baklouti F
    Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
    Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
    Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells.
    Breig O; Théoleyre-Schaal O; Baklouti F
    Cell Signal; 2013 Dec; 25(12):2453-61. PubMed ID: 23993958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.
    Delva L; Gallais I; Guillouf C; Denis N; Orvain C; Moreau-Gachelin F
    Oncogene; 2004 May; 23(25):4389-99. PubMed ID: 15064749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
    Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
    Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
    Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
    Delgado MD; Gutiérrez P; Richard C; Cuadrado MA; Moreau-Gachelin F; León J
    Biochem Biophys Res Commun; 1998 Nov; 252(2):383-91. PubMed ID: 9826539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.
    Kadri Z; Maouche-Chretien L; Rooke HM; Orkin SH; Romeo PH; Mayeux P; Leboulch P; Chretien S
    Mol Cell Biol; 2005 Sep; 25(17):7412-22. PubMed ID: 16107690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG; Spurlock DM
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2.
    Fujita T; Fukuyama R; Enomoto H; Komori T
    J Cell Biochem; 2004 Oct; 93(2):374-83. PubMed ID: 15368363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C.
    DeKoter RP; Geadah M; Khoosal S; Xu LS; Thillainadesan G; Torchia J; Chin SS; Garrett-Sinha LA
    J Immunol; 2010 Dec; 185(12):7374-84. PubMed ID: 21057087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon induces up-regulation of Spi-1/PU.1 in human leukemia K562 cells.
    Gutiérrez P; Delgado MD; Richard C; Moreau-Gachelin F; León J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):862-8. PubMed ID: 9398659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.
    Kosmider O; Denis N; Lacout C; Vainchenker W; Dubreuil P; Moreau-Gachelin F
    Cancer Cell; 2005 Dec; 8(6):467-78. PubMed ID: 16338660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
    Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
    Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
    Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
    Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.